글로벌 위식도 역류 질환 시장 – 2028년까지의 산업 동향 및 예측

시장 분석 및 통찰력: 글로벌 위식도 역류 질환 시장

위식도 역류 질환 시장은 2021년에서 2028년의 예측 기간 동안 시장 성장을 이룰 것으로 예상됩니다. Data Bridge Market Research는 위에서 언급한 예측 기간 동안 시장이 2.85%의 CAGR로 성장할 것으로 분석합니다. GERD 사례의 증가는 위식도 역류 질환 시장을 주도합니다.

역류성 식도염(GERD)은 속쓰림이라는 타는 듯한 느낌을 유발하는 질환의 한 유형으로 정의됩니다. 이것은 위의 염산이 함유된 내용물이 식도 하부로 다시 올라갈 때 발생하며, 이러한 역류를 역류라고 하며 타는 듯한 느낌을 유발합니다.

전 세계적으로 가격 조사를 받는 회사 수가 증가하는 것은 시장 성장을 가속화하는 중요한 요인이며, 소비자 접근성을 촉진하는 데 초점을 맞춘 정부의 변화, 의료 기기 수요 증가로 인해 다양한 회사가 신제품 개발 및 혁신에 집중하게 되었고, 속쓰림 사례가 증가하고 많은 제약 회사에서 수행하는 연구 개발 활동이 증가한 것이 위식도 역류 질환 시장을 주도하는 주요 요인입니다. 또한 의료 기기의 기술적 발전과 현대화가 증가하고 신흥 경제권에서 수요가 증가함에 따라 2021-2028년 예측 기간 동안 위식도 역류 질환 시장에 새로운 기회가 창출될 것입니다.

그러나 제품 리콜과 약물 부족은 시장 성장을 방해하는 주요 요인 중 하나이며, 위에서 언급한 예측 기간 동안 위식도 역류 질환 시장 성장을 더욱 어렵게 만들 것입니다.

Gastroesophageal reflux disease market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on gastroesophageal reflux disease market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Gastroesophageal Reflux Disease Market Scope and Market Size

Gastroesophageal reflux disease market is segmented on the basis of drug class, route of administration, end-users and distribution channel. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

• On the basis of drug class, gastroesophageal reflux disease market is segmented into antacids, proton pump inhibitors, H2 receptor blocker, pro-kinetic agents and others.
• Based on route of administration, the gastroesophageal reflux disease market is segmented into oral, parenteral and others.
• Based on end-users, the gastroesophageal reflux disease market is segmented into hospitals, homecare, specialty clinics and others.
• The gastroesophageal reflux disease market is also segmented on the basis of distribution channel into hospital pharmacy, online pharmacy and retail pharmacy.

Gastroesophageal Reflux Disease Market Country Level Analysis

Gastroesophageal reflux disease market is analysed and market size insights and trends are provided by country, drug class, route of administration, end-users and distribution channel as referenced above.

The countries covered in the gastroesophageal reflux disease market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the gastroesophageal reflux disease market due to rise in the shift in government focus on promoting consumer accessibility and increase in the demand of medical devices in this region. Asia-Pacific is the expected region in terms of growth in gastroesophageal reflux disease market due to rise in the geriatric population and lifestyle and dietary risk factors such as obesity & high fat diet in this region.

The country section of the gastroesophageal reflux disease market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Gastroesophageal reflux disease market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment’s, installed base of different kind of products for gastroesophageal reflux disease market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gastroesophageal reflux disease market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Gastroesophageal Reflux Disease Market Share Analysis

Gastroesophageal reflux disease market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to gastroesophageal reflux disease market.

위식도 역류 질환 시장 보고서에 포함된 주요 기업은 AstraZeneca, Eisai Co., Ltd, GlaxoSmithKline plc; Takeda Pharmaceutical Company Limited, Johnson & Johnson Services Inc, Mylan NV, Aurobindo Pharma, Cipla Inc, Zydus Cadila, Amneal Pharmaceuticals LLC, Sun Pharmaceuticals Industries Ltd, Lannett 등 국내 및 글로벌 기업입니다. 시장 점유율 데이터는 글로벌, 북미, 유럽, 아시아 태평양(APAC), 중동 및 아프리카(MEA) 및 남미에 대해 별도로 제공됩니다. DBMR 분석가는 경쟁 우위를 이해하고 각 경쟁자에 대한 경쟁 분석을 별도로 제공합니다.

SKU-44982